Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Eraxis. Always confirm against the full prescribing information.
100 interactions
Abacavir
Anidulafungin may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abiraterone
Anidulafungin may increase the hepatotoxic activities of Abiraterone.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Anidulafungin.
Level 2 evidence
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Anidulafungin.
Level 1 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Anidulafungin.
Level 2 evidence
Acetazolamide
Anidulafungin may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acitretin
Anidulafungin may increase the hepatotoxic activities of Acitretin.
Level 2 evidence
Albendazole
Anidulafungin may increase the hepatotoxic activities of Albendazole.
Level 2 evidence
Allopurinol
Anidulafungin may increase the hepatotoxic activities of Allopurinol.
Level 2 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hepatotoxic activities of Anidulafungin.
Level 2 evidence
Amiodarone
Anidulafungin may increase the hepatotoxic activities of Amiodarone.
Level 2 evidence
Asparaginase Escherichia coli
Asparaginase Escherichia coli may increase the hepatotoxic activities of Anidulafungin.
Eraxis (Anidulafungin) has 489 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Eraxis (Anidulafungin) has 1 major, 149 moderate, and 339 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Eraxis. Always confirm against the full prescribing information.